Fabry patients monitored in new enzyme therapy study

NCT ID NCT06880250

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: NPO Petrovax Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study watches 100 people with Fabry disease who are already taking enzyme replacement therapy as part of their regular care. Researchers want to see how the treatment affects their health over time by checking things like kidney function and pain levels. The study does not test a new drug—it simply collects information from routine doctor visits to better understand how the therapy works in real life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fabry disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FABRY DISEASE

Contacts and locations

Locations

#10

Krasnodar, Russia
#11

Ufa, Russia
#12

Ivanovo, Russia
#13

Astrakhan, Russia
#15

Orenburg, Russia
#16

Gubkin, Russia
#17

Omsk, Russia
#18

Kurgan, Russia
#19

Kaa-Khem, Russia
#2

Rostov-on-Don, Russia
#21

Grozny, Russia
#22

Stavropol, Russia
#23

Polevskoy, Russia
#24

Ryazan, Russia
#26

Irkutsk, Russia
#27

Barnaul, Russia
#3

Simferopol, Russia
#4

Rostov-on-Don, Russia
#5

Voronezh, Russia
#6

Chelyabinsk, Russia
#7

Borovichi, Russia
#8

Saint Petersburg, Russia
#9

Perm, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.